『徳島大学 教育・研究者情報データベース (EDB)』---[学外] /
ID: Pass:

登録内容 (EID=255296)

EID=255296EID:255296, Map:0, LastModified:2013年8月6日(火) 17:02:31, Operator:[丹黒 章], Avail:TRUE, Censor:0, Owner:[丹黒 章], Read:継承, Write:継承, Delete:継承.
種別 (必須): 学術論文 (審査論文) [継承]
言語 (必須): 英語 [継承]
招待 (推奨):
審査 (推奨):
カテゴリ (推奨):
共著種別 (推奨):
学究種別 (推奨):
組織 (推奨):
著者 (必須): 1.山本 洋太
役割 (任意):
貢献度 (任意):
学籍番号 (推奨):
[継承]
2. (英) Ikeda Mayumi (日) (読)
役割 (任意):
貢献度 (任意):
学籍番号 (推奨):
[継承]
3. (英) Takashima Mika (日) (読)
役割 (任意):
貢献度 (任意):
学籍番号 (推奨):
[継承]
4. (英) Minato Takuya (日) (読)
役割 (任意):
貢献度 (任意):
学籍番号 (推奨):
[継承]
5.古北 由仁
役割 (任意):
貢献度 (任意):
学籍番号 (推奨):
[継承]
6.武知 浩和
役割 (任意):
貢献度 (任意):
学籍番号 (推奨):
[継承]
7. (英) Seike Junichi (日) (読)
役割 (任意):
貢献度 (任意):
学籍番号 (推奨):
[継承]
8.丹黒 章 ([徳島大学.大学院医歯薬学研究部.医学域.医科学部門.外科系.胸部・内分泌・腫瘍外科学])
役割 (任意):
貢献度 (任意):
学籍番号 (推奨):
[継承]
題名 (必須): (英) [A case of a patient with stage IVa esophageal cancer surviving over 4 years by combination chemotherapy with docetaxel,5 -FU and cisplatin, without operation].  (日)    [継承]
副題 (任意):
要約 (任意): (英) A male patient in his 50s was found to have lower thoracic advanced esophageal squamous cell carcinoma by upper gastrointestinal endoscopy with the chief complaint of dysphagia in July 2006. CT revealed supraclavicular lymph node metastasis, and he was diagnosed as clinical stage IVa. He underwent two courses of combination chemotherapy with docetaxel, 5-FU and cisplatin(DFP therapy: docetaxel at 25mg/m / / 2 on day 1, 5-FU at 370 mg/m2 on days 1-5, and cisplatin at 7 mg/m2 on days 1-5 were repeated weekly for 4 weeks). The primary tumor disappeared and the lymph node was reduced as observed by upper gastrointestinal endoscopy and CT. After 2 courses of DFP therapy, PET-CT revealed that the primary tumor and lymph node had no new accumulation. Because he refused both operation and chemoradiotherapy, the patient underwent oral chemotherapy. In January 2010, PET-CT and upper gastrointestinal endoscopy revealed that the primary tumor relapsed. DFP therapy was performed and was effective once again. He has survived for over 4 years and 4 months without operation.  (日)    [継承]
キーワード (推奨): 1. (英) Antineoplastic Combined Chemotherapy Protocols (日) (読) [継承]
2. (英) Cisplatin (日) (読) [継承]
3. (英) Esophageal Neoplasms (日) (読) [継承]
4. (英) Fluorouracil (日) (読) [継承]
5. (英) Humans (日) (読) [継承]
6. (英) Male (日) (読) [継承]
7. (英) Middle Aged (日) (読) [継承]
8. (英) Neoplasm Staging (日) (読) [継承]
9. (英) Taxoids (日) (読) [継承]
10. (英) Tomography, X-Ray Computed (日) (読) [継承]
発行所 (推奨):
誌名 (必須): 癌と化学療法 (癌と化学療法社)
(pISSN: 0385-0684)

ISSN (任意): 0385-0684
ISSN: 0385-0684 (pISSN: 0385-0684)
Title: Gan to kagaku ryoho. Cancer & chemotherapy
Title(ISO): Gan To Kagaku Ryoho
Publisher: Japanese Journal of Cancer & Chemotherapy Publishers Inc.
 (NLM Catalog  (医中誌Web  (Scopus (Scopus information is found. [need login])
[継承]
[継承]
(必須): 38 [継承]
(必須): 8 [継承]
(必須): 1321 1324 [継承]
都市 (任意):
年月日 (必須): 西暦 2011年 8月 初日 (平成 23年 8月 初日) [継承]
URL (任意):
DOI (任意):
PMID (任意): 21829072    (→Scopusで検索) [継承]
NAID (任意):
WOS (任意):
Scopus (任意):
評価値 (任意):
被引用数 (任意):
指導教員 (推奨):
備考 (任意): 1.(英) Affiliation: Dept. of Surgery, Tokushima University Hospital.  (日)    [継承]
2.(英) PublicationType: Case Reports  (日)    [継承]
3.(英) PublicationType: English Abstract  (日)    [継承]
4.(英) PublicationType: Journal Article  (日)    [継承]

標準的な表示

和文冊子 ● Yota Yamamoto, Mayumi Ikeda, Mika Takashima, Takuya Minato, Yoshihito Furukita, Hirokazu Takechi, Junichi Seike and Akira Tangoku : [A case of a patient with stage IVa esophageal cancer surviving over 4 years by combination chemotherapy with docetaxel,5 -FU and cisplatin, without operation]., Japanese Journal of Cancer and Chemotherapy, Vol.38, No.8, 1321-1324, 2011.
欧文冊子 ● Yota Yamamoto, Mayumi Ikeda, Mika Takashima, Takuya Minato, Yoshihito Furukita, Hirokazu Takechi, Junichi Seike and Akira Tangoku : [A case of a patient with stage IVa esophageal cancer surviving over 4 years by combination chemotherapy with docetaxel,5 -FU and cisplatin, without operation]., Japanese Journal of Cancer and Chemotherapy, Vol.38, No.8, 1321-1324, 2011.

関連情報

Number of session users = 1, LA = 0.48, Max(EID) = 362800, Max(EOID) = 970590.